4,653 research outputs found
What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary
The aim of this commentary is to discuss the published Cochrane Review “Belimumab for systemic lupus erythematosus”1 by Singh et al.,a under the direct supervision of Cochrane Musculoskeletal Group. This Cochrane Corner is produced in agreement with International Journal of Rheumatic Diseases by Cochrane Rehabilitation
Osteoporosi: importanza di una corretta somministrazione di calcio nella terapia con i bisfosfonati
- …
